Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158793 · ClinicalTrials.gov registry record · NA
Craniomaxillofacial Allotransplantation
A NA study, sponsored by NYU Langone Health.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02158793 is a NA study that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 4 participants.
The verdict
NCT02158793, a NA study, was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to perform face transplants on people who have suffered severe facial trauma with tissue and functional loss; and evaluate the acceptance and function of the transplanted tissue. The aim of the transplant is to provide patient a more normal appearance . Additionally we aim to restore functioning, movement, and sensation of their face including that of the lips, mouth, and eyes.
Interventions
- PROCEDURE Craniomaxillofacial allotransplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-06 |
| Est. Completion | 2023-12-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02158793
The ClinicalTrials.gov registry entry for NCT02158793 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Craniomaxillofacial allotransplantation is the first listed.
NCT02158793 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02158793 about?
NCT02158793 is a clinical study titled "Craniomaxillofacial Allotransplantation". The purpose of this study is to perform face transplants on people who have suffered severe facial trauma with tissue and functional loss; and evaluate the acceptance and function of the transplanted tissue. The aim of the transplant is to provide patient a more normal appearance . Additionally we a...
What is the current status of trial NCT02158793?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2014-06. Estimated completion is 2023-12-11.
What interventions are being tested in trial NCT02158793?
The interventions under investigation include: Craniomaxillofacial allotransplantation (PROCEDURE).
Who is sponsoring clinical trial NCT02158793?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.